Application Information

This drug has been submitted to the FDA under the reference 021882/001.

Names and composition

"EXJADE" is the commercial name of a drug composed of DEFERASIROX.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
021882/001 EXJADE DEFERASIROX TABLET, FOR SUSPENSION/ORAL 125MG
021882/002 EXJADE DEFERASIROX TABLET, FOR SUSPENSION/ORAL 250MG
021882/003 EXJADE DEFERASIROX TABLET, FOR SUSPENSION/ORAL 500MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
021882/001 EXJADE DEFERASIROX TABLET, FOR SUSPENSION/ORAL 125MG
021882/002 EXJADE DEFERASIROX TABLET, FOR SUSPENSION/ORAL 250MG
021882/003 EXJADE DEFERASIROX TABLET, FOR SUSPENSION/ORAL 500MG
203560/001 DEFERASIROX DEFERASIROX TABLET, FOR SUSPENSION/ORAL 125MG
203560/002 DEFERASIROX DEFERASIROX TABLET, FOR SUSPENSION/ORAL 250MG
203560/003 DEFERASIROX DEFERASIROX TABLET, FOR SUSPENSION/ORAL 500MG
206910/001 JADENU DEFERASIROX TABLET/ORAL 90MG
206910/002 JADENU DEFERASIROX TABLET/ORAL 180MG
206910/003 JADENU DEFERASIROX TABLET/ORAL 360MG
207968/001 JADENU SPRINKLE DEFERASIROX GRANULE/ORAL 90MG
207968/002 JADENU SPRINKLE DEFERASIROX GRANULE/ORAL 180MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved